1. Home
  2. GWAV vs REVB Comparison

GWAV vs REVB Comparison

Compare GWAV & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GWAV
  • REVB
  • Stock Information
  • Founded
  • GWAV 2002
  • REVB 2020
  • Country
  • GWAV United States
  • REVB United States
  • Employees
  • GWAV N/A
  • REVB N/A
  • Industry
  • GWAV Packaged Foods
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • GWAV Consumer Staples
  • REVB Health Care
  • Exchange
  • GWAV Nasdaq
  • REVB Nasdaq
  • Market Cap
  • GWAV 3.7M
  • REVB 3.4M
  • IPO Year
  • GWAV N/A
  • REVB N/A
  • Fundamental
  • Price
  • GWAV $8.17
  • REVB $1.32
  • Analyst Decision
  • GWAV
  • REVB
  • Analyst Count
  • GWAV 0
  • REVB 0
  • Target Price
  • GWAV N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • GWAV 92.7K
  • REVB 296.8K
  • Earning Date
  • GWAV 11-14-2025
  • REVB 11-07-2025
  • Dividend Yield
  • GWAV N/A
  • REVB N/A
  • EPS Growth
  • GWAV N/A
  • REVB N/A
  • EPS
  • GWAV N/A
  • REVB N/A
  • Revenue
  • GWAV $33,315,859.00
  • REVB N/A
  • Revenue This Year
  • GWAV N/A
  • REVB N/A
  • Revenue Next Year
  • GWAV N/A
  • REVB N/A
  • P/E Ratio
  • GWAV N/A
  • REVB N/A
  • Revenue Growth
  • GWAV N/A
  • REVB N/A
  • 52 Week Low
  • GWAV $6.02
  • REVB $1.35
  • 52 Week High
  • GWAV $119.90
  • REVB $60.48
  • Technical
  • Relative Strength Index (RSI)
  • GWAV 63.79
  • REVB 29.32
  • Support Level
  • GWAV $6.41
  • REVB $1.40
  • Resistance Level
  • GWAV $8.74
  • REVB $1.69
  • Average True Range (ATR)
  • GWAV 0.70
  • REVB 0.11
  • MACD
  • GWAV -0.10
  • REVB 0.03
  • Stochastic Oscillator
  • GWAV 81.52
  • REVB 7.25

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: